New Small Molecule Agonists to the Thyrotropin Receptor

BACKGROUND: Novel small molecular ligands (SMLs) to the thyrotropin receptor (TSHR) have potential as improved molecular probes and as therapeutic agents for the treatment of thyroid dysfunction and thyroid cancer. METHODS: To identify novel SMLs to the TSHR, we developed a transcription-based lucif...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thyroid
Autors principals: Latif, Rauf, Ali, M. Rejwan, Ma, Risheng, David, Martine, Morshed, Syed A., Ohlmeyer, Michael, Felsenfeld, Dan P., Lau, Zerlina, Mezei, Mihaly, Davies, Terry F.
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2015
Matèries:
Original StudiesThyroid Dysfunction: Hypothyroidism, Thyrotoxicosis, and Thyroid Function Tests
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4291085/
https://ncbi.nlm.nih.gov/pubmed/25333622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2014.0119
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars